Finance

Lists
002294:SHE
Shenzhen Salubris Pharmaceuticals Co Ltd
CN¥29.89
-1.19%
(-0.36) 1D
Oct 30, 3:04:42 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002294...
Open
CN¥30.03
High
CN¥30.70
Low
CN¥29.71
Mkt. cap
33.32B
Avg. vol.
11.55M
Volume
11.04M
Dividend
1.84%
Quarterly dividend
CN¥0.14
Ex-dividend date
May 26, 2026
P/E ratio
46.42
52-wk high
CN¥70.99
52-wk low
CN¥29.25
EPS
CN¥0.64
Shares outstanding
1.11B
No. of employees
4K
Open
CN¥30.03
High
CN¥30.70
Low
CN¥29.71
Mkt. cap
33.32B
Avg. vol.
11.55M
Volume
11.04M
Dividend
1.84%
Quarterly dividend
CN¥0.14
Ex-dividend date
May 26, 2026
P/E ratio
46.42
52-wk high
CN¥70.99
52-wk low
CN¥29.25
EPS
CN¥0.64
Shares outstanding
1.11B
No. of employees
4K
News stories
From web sources and news partners
Profile
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company. Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019. Shenzhen Salubris is headed by the billionaire Ye Chenghai. Wikipedia
About Shenzhen Salubris Pharmaceuticals Co Ltd
CEO-
Employees4.09K
FoundedNov 3, 1998
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.11B
1.23B
1.25B
1.26B
Cost of goods sold
302.88M
287.67M
343.20M
334.97M
Cost of revenue
302.88M
287.67M
343.20M
334.97M
Research and development expenses
176.44M
131.32M
139.63M
121.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
568.30M
551.61M
596.71M
523.94M
Operating expense
770.11M
694.36M
749.18M
639.86M
Total operating expenses
1.07B
982.03M
1.09B
974.84M
Operating income
38.38M
246.41M
158.32M
288.81M
Other non operating income
13.83M
-5.27M
5.40M
-56.88M
EBT including unusual items
5.21M
255.47M
142.37M
286.95M
EBT excluding unusual items
72.00M
252.02M
160.96M
275.17M
Income tax expense
-56.18M
29.65M
-22.28M
30.51M
Effective tax rate
-1,078.48%
11.60%
-15.65%
10.63%
Other operating expenses
34.11M
9.61M
16.33M
-6.53M
Net income
70.80M
225.27M
161.82M
257.11M
Net profit margin
6.37%
18.34%
12.94%
20.35%
Earnings per share
-
-
-
-
Interest and investment income
37.76M
15.05M
12.29M
39.56M
Interest expense
-7.50M
-4.17M
-4.97M
-6.40M
Net interest expenses
30.27M
10.88M
7.32M
33.15M
Depreciation and amortization charges
-
-
-
-
EBITDA
135.48M
343.52M
257.90M
385.91M
Gain or loss from assets sale
3.03M
-
166.24K
-166.24K
Upcoming events
AI content may include mistakes. Learn more
Google apps